Bone Biologics Corp Stock Market Value
| BBLGW Stock | USD 27.80 0.69 2.42% |
| Symbol | Bone |
Bone Biologics Corp Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.14) | Return On Assets (0.57) | Return On Equity (1.19) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bone Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bone Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bone Biologics.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Bone Biologics on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Bone Biologics Corp or generate 0.0% return on investment in Bone Biologics over 30 days. Bone Biologics is related to or competes with Bone Biologics, Biofrontera Warrants, and Inspira Technologies. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinan... More
Bone Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bone Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bone Biologics Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.048 | |||
| Maximum Drawdown | 183.08 | |||
| Value At Risk | (1.43) |
Bone Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bone Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bone Biologics' standard deviation. In reality, there are many statistical measures that can use Bone Biologics historical prices to predict the future Bone Biologics' volatility.| Risk Adjusted Performance | 0.0508 | |||
| Jensen Alpha | 1.77 | |||
| Total Risk Alpha | (2.70) | |||
| Treynor Ratio | (0.32) |
Bone Biologics Corp Backtested Returns
Bone Biologics is relatively risky given 3 months investment horizon. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of 0.0546, which signifies that the company had a 0.0546% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-one different technical indicators, which can help you to evaluate if expected returns of 1.32% are justified by taking the suggested risk. Use Bone Biologics Risk Adjusted Performance of 0.0508, mean deviation of 5.38, and Standard Deviation of 23.73 to evaluate company specific risk that cannot be diversified away. Bone Biologics holds a performance score of 4 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.96, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bone Biologics are expected to decrease by larger amounts. On the other hand, during market turmoil, Bone Biologics is expected to outperform it. Use Bone Biologics variance, skewness, as well as the relationship between the Skewness and day typical price , to analyze future returns on Bone Biologics.
Auto-correlation | 0.99 |
Perfect predictability
Bone Biologics Corp has perfect predictability. Overlapping area represents the amount of predictability between Bone Biologics time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bone Biologics Corp price movement. The serial correlation of 0.99 indicates that 99.0% of current Bone Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.99 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Bone Biologics Corp lagged returns against current returns
Autocorrelation, which is Bone Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bone Biologics' stock expected returns. We can calculate the autocorrelation of Bone Biologics returns to help us make a trade decision. For example, suppose you find that Bone Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bone Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bone Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bone Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bone Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
Bone Biologics Lagged Returns
When evaluating Bone Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bone Biologics stock have on its future price. Bone Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bone Biologics autocorrelation shows the relationship between Bone Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Bone Biologics Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bone Stock Analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.